losclouds
Service profile

Eledon Pharmaceuticals, Inc.Eledon Pharmaceuticals, Inc.

Develops tegoprubart, an anti-CD40L antibody therapy designed to prevent rejection in kidney transplant recipients and treat other autoimmune conditions by blocking CD40-CD40L signaling pathway without platelet-related side effects of earlier approaches.

About

What Eledon Pharmaceuticals, Inc. is

Develops tegoprubart, an anti-CD40L antibody therapy designed to prevent rejection in kidney transplant recipients and treat other autoimmune conditions by blocking CD40-CD40L signaling pathway without platelet-related side effects of earlier approaches.

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Eledon Pharmaceuticals, Inc. service facts
FactValue
Official sitehttps://eledonpharmaceuticals.com
Status coveragePublic status page
Founded2019
HeadquartersIrvine, California, United States
CategoriesEnterprise, Healthcare
Loading offerings...